Meningococcal case reported in Maldives; HPA begins tracing and prophylaxis

07 Jun 2025 | 18:20
Meningococcal rash (Photo/Ausmed)

The Health Protection Agency (HPA) has confirmed the identification of a meningococcal disease case in the Maldives and has initiated a series of protective measures in response.

According to the HPA, contact tracing was promptly conducted, and prophylactic antibiotics were administered to individuals identified as high-risk contacts.

The agency noted that further preventive steps are being taken to minimize the risk of transmission.

Meningococcal disease is a serious and contagious infection caused by the Neisseria meningitidis bacterium.

It often leads to meningitis or bloodstream infections, particularly among vulnerable populations.

While the number of cases reported in the Maldives remains low, they are typically linked to individuals who acquired the infection while overseas.

Common symptoms of the disease include

- Fever

- Headaches

- Neck stiffness

- Distinctive red or purple rash on the skin

In severe cases, the infection can affect the brain causing meningitis or lead to widespread sepsis.

The disease spreads primarily through respiratory droplets and direct contact, with symptoms typically appearing between 1 to 10 days after exposure.

The HPA continues to monitor the situation closely and advises the public to remain vigilant for symptoms and seek medical attention if necessary.

Comments